American Oncology Network Inc - Ordinary Shares - Class A

XNAS: AONC

Download real time

4.75 -0.05 (-1.04%)

370.30% Gain from 52W Low

100 XNAS Volume

XNAS 03 Apr, 2025 5:30 PM (EDT)

138.9

Market Cap

Below industry Median

0.0

Beta 1Year

Very Low volatility

Insider Trading disclosures for American Oncology Network Inc - Ordinary Shares - Class A

The latest disclosure was made by Stephen Divers in American Oncology Network Inc - Ordinary Shares - Class A where a trade of 5,000 Class A Common Stock done at an average price of $2.2 was reported to US exchanges on May 24, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Stephen Divers	Director, Chief Medical Officer	Purchase of securities on an exchange or from another person at price $ 2.15 per share.	24 May 2024	5,000	62,470	-	2.2	10,750	Class A Common Stock
Todd Schonherz	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 1.87 per share.	21 May 2024	4,000	4,000	-	1.9	7,480	Class A Common Stock
Todd Schonherz	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 1.86 per share.	21 May 2024	340	5,340	-	1.9	632	Class A Common Stock
Todd Schonherz	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 1.85 per share.	21 May 2024	1,000	5,000	-	1.9	1,850	Class A Common Stock
Bradley M. Fluegel	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 May 2024	14,981	39,981	-		0	Class A Common Stock
William Valle	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 May 2024	14,981	14,981	-		0	Class A Common Stock
Stephen Divers	Director, Chief Medical Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.70 per share.	20 Mar 2024	8,554	57,470	-	5.7	48,758	Class A Common Stock
Stephen Divers	Director, Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 5.69 per share.	19 Mar 2024	59,500	66,024	-	5.7	338,555	Class A Common Stock
Stephen Divers	Director, Chief Medical Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.10 per share.	05 Jan 2024	3,369	6,524	-	6.1	20,551	Class A Common Stock
Stephen Divers	Director, Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2024	9,893	9,893	-		0	Class A Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

Screeners based on Insider Trading and SAST parameters